Medinol, a company based in Tel Aviv, Israel, has announced that its EluNIR drug eluting stent received the CE Mark of approval in Europe. The device is coated with ridaforolimus to help prevent restenosis and is designed be both highly flexible while maintaining flexibility, making it easier to reach and penetrate difficult lesions.
The company (Read more...)